Medlive Technology Co., Ltd. (HKG:2192)
Hong Kong
· Delayed Price · Currency is HKD 12.20
+0.18 (1.50%)
Apr 24, 2025, 4:08 PM HKT
Medlive Technology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 3,845 | 4,358 | 4,187 | 3,879 | 147.1 | Upgrade
|
| Short-Term Investments | 205.6 | 5.21 | 4.66 | 4.88 | 1.6 | Upgrade
|
| Trading Asset Securities | 102.15 | 42.64 | 29.64 | 29.64 | - | Upgrade
|
| Cash & Short-Term Investments | 4,152 | 4,406 | 4,222 | 3,914 | 148.7 | Upgrade
|
| Cash Growth | -5.76% | 4.37% | 7.87% | 2531.98% | 263.94% | Upgrade
|
| Receivables | 174.85 | 155.92 | 124.21 | 95.87 | 58.24 | Upgrade
|
| Inventory | - | 0.1 | 0.2 | 0.09 | - | Upgrade
|
| Other Current Assets | 29.18 | 10.46 | 5.76 | 3.41 | 1.43 | Upgrade
|
| Total Current Assets | 4,356 | 4,573 | 4,352 | 4,013 | 208.36 | Upgrade
|
| Property, Plant & Equipment | 38.05 | 11.08 | 14.57 | 16.87 | 15.19 | Upgrade
|
| Long-Term Investments | 440.73 | 42.37 | 92.79 | 0.34 | - | Upgrade
|
| Goodwill | 192.53 | 192.53 | 111.52 | 69.72 | - | Upgrade
|
| Other Intangible Assets | 29.44 | 27.54 | 16.19 | 9.3 | - | Upgrade
|
| Long-Term Deferred Tax Assets | 8.26 | 8.52 | 8.28 | 6.33 | 3.51 | Upgrade
|
| Long-Term Deferred Charges | 42.69 | 39.2 | 8.14 | - | - | Upgrade
|
| Total Assets | 5,108 | 4,894 | 4,603 | 4,116 | 227.06 | Upgrade
|
| Accounts Payable | 13.86 | 14.77 | 2.71 | 6.22 | 6.27 | Upgrade
|
| Accrued Expenses | 79.37 | 74.55 | 62.85 | 45.79 | 25.36 | Upgrade
|
| Current Portion of Leases | 11.6 | 4.55 | 5.14 | 4.21 | 2.59 | Upgrade
|
| Current Income Taxes Payable | 14.69 | 16.97 | 25.03 | 24.22 | 9.99 | Upgrade
|
| Current Unearned Revenue | 49.71 | 43.77 | 12.81 | 7.81 | 19.64 | Upgrade
|
| Other Current Liabilities | 37.87 | 35.16 | 24.21 | 24.97 | 0.23 | Upgrade
|
| Total Current Liabilities | 207.11 | 189.77 | 132.75 | 113.21 | 64.08 | Upgrade
|
| Long-Term Leases | 11.03 | 3.64 | 6.13 | 8.96 | 9.48 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 8.71 | 7.54 | 4.64 | 2.71 | 2.08 | Upgrade
|
| Other Long-Term Liabilities | 26.72 | 47.66 | 27.8 | 18.49 | - | Upgrade
|
| Total Liabilities | 253.57 | 248.61 | 171.32 | 143.37 | 75.65 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.05 | 0.04 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 3,906 | 3,904 | 3,898 | 3,898 | 10.06 | Upgrade
|
| Retained Earnings | 448.18 | 312.07 | 194.46 | 89.27 | 140.65 | Upgrade
|
| Comprehensive Income & Other | 444.9 | 381.6 | 308.13 | -39.01 | 0.67 | Upgrade
|
| Total Common Equity | 4,799 | 4,597 | 4,401 | 3,949 | 151.41 | Upgrade
|
| Minority Interest | 55.59 | 47.83 | 30.89 | 23.49 | - | Upgrade
|
| Shareholders' Equity | 4,855 | 4,645 | 4,432 | 3,972 | 151.41 | Upgrade
|
| Total Liabilities & Equity | 5,108 | 4,894 | 4,603 | 4,116 | 227.06 | Upgrade
|
| Total Debt | 22.63 | 8.19 | 11.26 | 13.17 | 12.08 | Upgrade
|
| Net Cash (Debt) | 4,130 | 4,398 | 4,210 | 3,900 | 136.62 | Upgrade
|
| Net Cash Growth | -6.10% | 4.46% | 7.94% | 2754.96% | 278.92% | Upgrade
|
| Net Cash Per Share | 5.61 | 5.99 | 5.72 | 6.13 | 0.26 | Upgrade
|
| Filing Date Shares Outstanding | 732.88 | 726.96 | 717.35 | 713.23 | 535.08 | Upgrade
|
| Total Common Shares Outstanding | 732.88 | 726.96 | 717.35 | 713.23 | 535.08 | Upgrade
|
| Working Capital | 4,149 | 4,383 | 4,219 | 3,900 | 144.28 | Upgrade
|
| Book Value Per Share | 6.55 | 6.32 | 6.14 | 5.54 | 0.28 | Upgrade
|
| Tangible Book Value | 4,577 | 4,377 | 4,273 | 3,870 | 151.41 | Upgrade
|
| Tangible Book Value Per Share | 6.25 | 6.02 | 5.96 | 5.43 | 0.28 | Upgrade
|
| Machinery | 9.35 | 8.08 | 7.21 | 5.87 | 3.19 | Upgrade
|
| Leasehold Improvements | 10.67 | 7.07 | 7.07 | 7.07 | 6.64 | Upgrade
|
Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.